Stay updated on Pembrolizumab Neoadjuvant in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Neoadjuvant in HCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A government funding/operating status notice was added, with links to cc.nih.gov and opm.gov, and the site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T05:58:07.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated the page footer to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the previous entries Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T04:22:30.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision was updated from v3.3.3 to v3.3.4; no visible changes to the study details.
    Difference
    0.1%
    Check dated 2026-01-14T01:27:49.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new site revision note 'Revision: v3.3.3' appears in the footer, and the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' items were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:26:41.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.1 to v3.3.2, indicating a minor page revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:50:43.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page revision updated from v3.2.0 to v3.3.1; there are no changes to trial details or core information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:46:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Neoadjuvant in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.